Zyvox – new generation antibiotic
Zyvox is highly effective against gram-positive microorganisms(staphylococcus, enterococcus, pneumococcus, streptococcus, anaerobic coccus and some other microbes. Zyvox is quickly absorbed into blood and reaches maximal concentration in blood in 1-2 hours and makes about 12 microgram per 1 ml. The absolute bioavailability of the medicine makes up 100%. Taking the medicine with food reduces the maximal concentration in blood by 23% , but at the same time bioavailability does not change. Linezolid is used for treating infections of various locations both in children and adults, caused by gram-positive microorganisms (staphylococcus, pneumococcus, enterococcus): uncomplicated skin and soft tissue infections in ambulance situation; acute pneumonia, complicated urinary tract infections, bacteriemia or sepsis; intra-abdominal infections; infective endocarditis. Zyvox (Linezolid) is especially recommended for treating severe infections with dominating gram-positive causative microorganisms. Zyvo allows carrying out step therapy which provides better tolerability and comfort and makes it possible to be discharged from hospital sooner and continue treatment in an out-patient mode.
Tags: Antibiotics, Linezolid, Zyvox